rs7587103
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001378454.1(ALMS1):c.6007A>G(p.Ile2003Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000765 in 1,614,038 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00369 AC: 561AN: 152174Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.00105 AC: 261AN: 249114Hom.: 0 AF XY: 0.000851 AC XY: 115AN XY: 135142
GnomAD4 exome AF: 0.000460 AC: 672AN: 1461746Hom.: 2 Cov.: 38 AF XY: 0.000417 AC XY: 303AN XY: 727178
GnomAD4 genome AF: 0.00370 AC: 563AN: 152292Hom.: 3 Cov.: 32 AF XY: 0.00336 AC XY: 250AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:4
p.Ile2002Val in exon 8 of ALMS1: This variant is not expected to have clinical s ignificance because it has been identified in 1.27% (124/9766) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs7587103). -
- -
Variant summary: ALMS1 c.6004A>G (p.Ile2002Val) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 393874 control chromosomes, predominantly at a frequency of 0.013 within the African or African-American subpopulation in the gnomAD database, including 4 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 6 fold of the estimated maximal expected allele frequency for a pathogenic variant in ALMS1 causing Cardiomyopathy phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.6004A>G in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Six submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign (n = 3) or likely benign (n = 3). Based on the evidence outlined above, the variant was classified as benign. -
- -
not provided Benign:4
- -
- -
- -
- -
Alstrom syndrome Benign:2
Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs7587103 in Alstrom syndrome yet. -
- -
Monogenic diabetes Benign:1
ACMG criteria: BP4(8 predictors, REVEL=0.017),BS1(1.27% in ExAC African population), BP1(missense in gene with truncating cause disease), 1 homozygote in gnomAD=likely benign -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at